Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer
Clinical trial NCT06255392 · RECRUITING
Trial details
- NCT number
- NCT06255392
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-12
- Primary completion
- 2031-03-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.